Overview

• Health undersecretary Eduardo Clark said at least 33 contracted providers failed to deliver, naming Bioxintegral Servicios with 100% undelivered, Productos Farmacéuticos at 88.6%, Serral at 83.7%, and Puerta del Sol Capital with 14.1 million pieces short of 21.3 million contracted.
• Officials reported supply levels near full coverage with IMSS at about 97%, ISSSTE similar, IMSS-Bienestar at 92%, and oncological medicines at 96%, attributing the remaining gap to vendor noncompliance.
• President Claudia Sheinbaum announced a one-month window for delinquent firms to fulfill obligations and warned of disqualification, while the Anticorruption and Good Governance Secretariat enables replacement purchases at contracted prices.
• IMSS-Bienestar’s second distribution phase began on September 22 targeting 8,342 centers with 9,632 preassembled kits across 1,132 routes, following an August round that delivered 11,364 kits and more than 28 million doses to 8,061 clinics and 578 hospitals.
• Cancer drugs are being shipped directly from the national megafarmacia to about 56 IMSS-Bienestar specialty centers, and officials highlighted oncology shortfalls by firms such as Accord Farma at 55% undelivered and Zurich Pharma at 18.3%.